Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the Compliance, Legal, Internal Controls, Finance and Human Resources groups (the “Recoupment Committee”). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. A Covered Executive shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the business units engaged in Covered Functions (as defined in Section II.E.6 of the CIA), Legal, and Compliance (Recoupment Committee). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. An Eligible Individual shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination. If a Recoupment Determination involves an Executive Officer of Insys, a Recoupment Determination for such individual shall be subject to approval by the Board of Directors (or appropriate committee thereof) of Insys. If an Executive Officer or other Eligible Individual is subject to a Recoupment Determination and is a member of the Board of Directors, that individual shall not participate in the Board’s approval process. For purposes of this Section, “Executive Officer” means any Executive Officer of the Registrant, as described in Insys’s Annual Report to the SEC, the Corporate Controller, and such other executives of Insys subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934, as amended, as may be determined by the Company’s Board of Directors.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives headed by the Senior Vice President for Governance, Ethics, and Assurance of GlaxoSmithKline PLC (Recoupment Committee). With respect to members of the CET, a Recoupment Determination shall be subject to ratification by the Board of Directors (or appropriate committee thereof) of GlaxoSmithKline PLC.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the Ethics, Risk & Compliance, People & Organization, Legal, Finance, and Internal Audit groups (Recoupment Committee). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. A Covered Executive shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination. If a Recoupment Determination involves an Executive Officer of Sandoz, a Recoupment Determination for such individual shall be subject to approval by the Board of Directors (or appropriate committee thereof) of Sandoz.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the Compliance, Legal, Internal Controls, Finance and Human Resources groups (Recoupment Committee). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. A Covered Executive shall not participate in the Recoupment Committee while that Covered Executive is subject to a Recoupment Determination. If a Recoupment Determination involves an executive officer (e.g., Chief Executive Officer, Chief Financial Officer, etc.) of Mallinckrodt, a Recoupment Determination for such individual shall be subject to approval by the Board of Directors (or appropriate committee thereof) of Mallinckrodt.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives headed by Par’s Compliance Officer (Recoupment Committee). A senior executive shall not participate in the Recoupment Committee while the subject of a Recoupment Determination. If a Recoupment Determination involves the President; Chief Executive Officer; Chief Financial Officer; Compliance Officer; Senior Vice President of Sales, Strativa; Senior Vice President of Sales, Par Pharmaceutical; and Vice President, Regulatory Affairs, a Recoupment Determination for such individual shall be subject to ratification by the Board of Directors (or appropriate committee thereof) of Par. Par’s Board of Directors may, in its discretion, provide that the Recoupment Committee shall consist exclusively of non- employee members of the Board of Directors if at least three such non-employee members are appointed to serve as the Recoupment Committee. Par shall notify OIG in writing within 15 days of any change in the composition of the Recoupment Committee with an explanation for the change.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the Compliance, Legal, Internal Controls, Finance and Human Resources groups (Recoupment Committee). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. A Covered Executive shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination. If a Recoupment Determination involves an Executive Officer of Taro, a Recoupment Determination for such individual shall be subject to approval by the Board of Directors (or appropriate committee thereof) of Taro.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the business units engaged in
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior executives representing the Compliance, Legal, Internal Controls, Finance and Human Resources groups (Recoupment Committee). The Recoupment Committee may also include members of other functional areas or business groups, as it deems necessary. A Covered Executive shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination. If a Recoupment Determination involves an Executive Officer of J&J, a Recoupment Determination for such individual shall be subject to approval by the Board of Directors (or appropriate committee thereof) of J&J. For purposes of this section, “Executive Officer” means any member of the Executive Committee of J&J, the Corporate Controller, and such other executives of J&J subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934, as amended, as may be determined by the Company’s Board of Directors.
Recoupment Committee. The Recoupment Determination shall be made by a committee of senior Novelion and/or Aegerion executives headed by the Novelion Global Chief Compliance Officer and further consisting of the Novelion General Counsel and the Novelion Senior Vice President Human Resources (together, the “Recoupment Committee”). A senior executive shall not participate in the Recoupment Committee while that individual is subject to a Recoupment Determination. If a Recoupment Determination involves a member of the Recoupment Committee, such individual is recused from the Recoupment Committee for purposes of the Recoupment Determination and the remaining members of the Recoupment Committee may replace such individual with a Delegate, as defined below in Section II.C.3 Novelion’s Board may, in its discretion, provide that the Recoupment Committee shall consist exclusively of non-employee members of the Board if at least three such non-employee members are appointed to serve as the Recoupment Committee. Aegerion shall notify OIG in writing within 15 days of any change in the composition of the Recoupment Committee and provide an explanation for the change.
